期刊文献+

磁珠分离结合定量PCR法检测单克隆抗体产品中CHO细胞DNA残留量 被引量:14

Determination of residual host cell DNA in monoclonal antibody products by magnetic bead based extraction combined with quantitative PCR
原文传递
导出
摘要 目的 利用磁珠分离法结合定量PCR技术,建立单克隆抗体产品中CHO细胞DNA残留量的检测方法,并进行验证及初步应用。方法通过磁珠分离法提取样品中的残留DNA,再利用Taqman探针法对样品和标准DNA进行定量PCR测定,根据标准曲线对样品中的DNA残留量进行分析。对建立的方法进行种属特异性、准确性及精密性验证,并对5个厂家15批单克隆抗体类产品中的残留DNA进行测定。结果该方法检测CHO细胞DNA残留的最低准确定量浓度可达1×10^-3pg/μl,DNA含量在1×10^-3~10^2 pg/μl范围内曲线线性良好,标准曲线的相关系数为0.994;该方法能特异性地检测CHO细胞DNA,对其他种属的DNA无扩增反应;该方法检测不同DNA加标量样品的DNA回收率相近,均值均在90%以上,3次测定的相对标准偏差均小于20%,92.6%加标样品的DNA回收率在70%~130%之间;该方法检测15批单克隆抗体类产品的DNA残留量均小于100pg/剂量,符合《中国药典》三部(2010版)有关CHO细胞残余DNA的要求。结论磁珠分离法可解决残留DNA检测中样品前处理的技术难点,定量PCR法能够简便、快速、准确地对不同工艺的单克隆抗体产品中CHO细胞DNA残留进行定量测定。 Objective To develop, verify and preliminarily apply a magnetic bead based extraction combined with quantitative PCR (q-PCR) method for determination of residual host cell DNA in monoclonal antibody (McAb) products. Methods The residual host cell DNA in test samples was extracted by magnetic bead based extraction method, and determined by Taqman probe based q-PCR, using standard DNA as control The residual DNA content was analyzed according to the standard curve. The developed method was verified for specificity, accuracy and precision, and used for determination of 15 batches of McAb products from five manufacturers. Results The minimum detection limit of residual CHO cell DNA by the developed method was 1 × 10^-3 pg/μl, while the linear range was 1 × 10^-3 ~ 1× 102 pg/μl, with a correlation coefficient (r value) of 0. 994. The q-PCR method was specific for CHO DNA, which showed no responses to the DNAs of other species. The recovery rates of spiked samples of various concentrations were more than 90%, of which the relatively standard deviations in 3 tests were less than 20%. However, the DNA recovery rates of 92.6% of spike samples were within 70%~130%. All the residual DNA contents in 15 batches of McAb products determined by the developed method were less than 100 pg per dose, which were complied with the requirements for residual CHO cell DNA in Chinese Pharmacopeia (Volume Ⅲ, 2010 edition). Conclusion The magnetic bead based extraction method successfully solved the technical difficulties of sample pretreatment during residual DNA assay. The q-PCR method was simple, rapid and accurate for quantitation of residual CHO cell DNA in McAb products manufactured by various procedures.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第4期555-558,共4页 Chinese Journal of Biologicals
基金 国家"重大新药创制"科技重大专项(2012ZX09304010)
关键词 磁珠分离法 定量聚合酶链反应 CHO细胞 DNA残留 单克隆抗体 质量控制 Magnetic bead based extraction Quantitative PCR (q-PCR) CHO cells Residual DNA Monoclonal antibody Quality control
  • 相关文献

参考文献9

  • 1WHO Expert Committee on Biological Standardization. Forty- seventh Report. Requirements for the use of animal cells as in vitro substrates for the production of biologicals [ S ]. Geneva:World Health Organization, 1998.
  • 2WHO Study Group. Acceptability of cell substrates for produc- tion of hiologicals [J]. WHO TRS, 1987, 747: 1-29.
  • 3WHO Expert Committee on Biological Standardization. Thirty sixth Report. Requirements for continuous cell lines used for biological production [S]. Geneva: World Health Organization, 1987.
  • 4WHO Expert Committee on biological standardization. Recom- mendations for the evaluation of animal cell cultures as sub- strates for the manufacture of biological medicinal products and for the characterization of cell banks [ S ]. Geneva: World Health Organization, 2010.
  • 5王兰,王军志.关于生物制品残余DNA质量控制问题[J].中国新药杂志,2011,20(8):678-683. 被引量:42
  • 6Robertson JS, Heath AB. A collaborative study on DNA quanti- tation in biological products [ J ]. Biologicals, 1995, 23 ( 3 ) : 199-205.
  • 7王兰,高凯,毕华,李永红,饶春明.荧光法和DNA杂交法检测重组技术产品中残余DNA的比较[J].药物分析杂志,2009,29(7):1063-1066. 被引量:31
  • 8国家药典委员会.中国药典(三部)[s].北京:中国医药科技出版社,2010:111-114.
  • 9王兰,高凯,范文红,毕华,付志浩,李永红,饶春明.中国仓鼠卵巢细胞DNA国家标准品的研制[J].中国药学杂志,2013,48(1):68-72. 被引量:9

二级参考文献45

  • 1饶春明,赵阳,李永红,王军志.应用荧光法测定重组细胞因子中残余DNA含量[J].药物分析杂志,2005,25(12):1417-1419. 被引量:23
  • 2EU. Position statement on the use of tumorigenic cells of human origin for the production of biological and bioteehnological medicinal products. The European Agency for the Evaluation of Medieinal Products : Evaluation of medicinal products for human use. CPMP/BWP/1143/ 00 2001.
  • 3FDA. Points to consider in the manufacture and testing of monoclonal antibody products for human use. US Department of Health and Human Services,Food and Drug Administration, Center for Biologics Evaluation and Research 1997.
  • 4WANG Jun-zhi(王军志).Research & Development and Quality Control of Biotechnical Drugs(2nd Ed)(生物技术药物研究开发和质量控制)(第二版).Beijing(北京):Science Press(科学出版社),2007.98.
  • 5Singer VL, Jones LJ, Yue ST, et al. Characterization of PicoGreen reagent and development of a fluorescence - based solution assay for double - stranded DNA quantitation. Anal Biochem, 1997,249 ( 2 ) : 228.
  • 6苗玉发,王欣,沈连忠,李波.治疗性HIV腺病毒载体疫苗的生物分布[J].毒理学杂志,2007,21(4):313-314. 被引量:3
  • 7WHO Expert Committee on Biological Standardization. Forty-seventh Report. Requirements for the use of animal ceils as in vitro substrates for the production of biologicals [ R ]. Geneva: World Health Organization, 1998 (WHO Technical Report Series, No. 878, annex 1).
  • 8WHO Study Group. Acceptability of cell substrates for production of biologicals [ R ]. 1987 ( W HO Technical Report Series, No 747 ).
  • 9WHO Expert Committee on Biological Standardization. Thirtysixth Report. Requirements for continuous cell lines used for biological production [ R ]. Geneva: World Health Organization, 1987, Annex 3 ( WHO Technical Report Series, No. 745 ).
  • 10WHO expert committee on biological standardization. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks [ R ]. Geneva: World Health Organization, 18 -22 October 2010.

共引文献95

同被引文献107

引证文献14

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部